Physical Therapists in Awendaw, SC Accepting Medicare
4 Physical Therapists found. Showing 1 - 4
 Leah Mcconnell, MHSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 751 Seewee Bluff Rd, Awendaw, SC 29429 Phone: 843-670-7246 |
 Palmetto Children's Therapy, Llc Physical Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 856 Grannys Ln, Awendaw, SC 29429 Phone: 843-259-4633 Fax: 843-388-4498 |
Mrs. Jill Kelley Beasenburg, PT Physical Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 856 Grannys Ln, Awendaw, SC 29429 Phone: 843-259-4633 Fax: 843-388-4498 |
High Tide Pediactric Therapy Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3909 Sawmill Ct, Awendaw, SC 29429 Phone: 814-282-7499 |
News Archive
New TAXUS Liberté Stent demonstrates superior results for treating long lesions
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX), has released comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS(R) Liberté(R) Paclitaxel-Eluting Stent System in a variety of lesions and patient groups. Three-year results from the TAXUS ATLAS Small Vessel and Long Lesion Trials continue to show significant advantages for the newer TAXUS Liberté Stent when compared to the first-generation TAXUS(R) Express(R) Stent.
Study highlights the importance of reducing air pollution to prevent heart attacks
Reduced air pollution in the U.S. during the COVID-19 shutdown initiated in March 2020 was linked to fewer severe heart attacks, according to preliminary research to be presented at the American Heart Association's Scientific Sessions 2021.
Researchers identify factors linked to poor outcomes in patients with childhood-onset lupus
UT Southwestern researchers have identified factors that put patients with childhood-onset lupus at elevated risk for poor outcomes, such as end-stage renal disease or death, as they transition from pediatric to adult health care.
Progenics Pharmaceuticals to advance oral methylnaltrexone for OIC into late stage clinical development
Progenics Pharmaceuticals, Inc. today announced that it plans to advance oral methylnaltrexone for the treatment of opioid-induced constipation (OIC) into late stage clinical development and will commence a phase 2b/3 clinical trial of a methylnaltrexone tablet in chronic-pain patients in the second half of 2010. Progenics also announced data from a clinical trial of this methylnaltrexone tablet.
Two out of three survivors of childhood cancer have at least one chronic or late-occurring health problem following their cancer therapy
A review in the July/August issue of "CA: A Cancer Journal for Clinicians" reports that two out of three survivors of childhood cancer have at least one chronic or late-occurring health problem following their cancer therapy, with about one in three having serious or life-threatening complications. These effects are often seen decades after therapy.
› Verified 2 days ago
Physical Therapists
Occupational Therapists
Speech-Language Pathologists